Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4011871

CCC1=Cc2ccc3ccccc3c2C1[Zr](C)(C)(=[SiH2])C1C(CC)=Cc2ccc3ccccc3c21.Cl.Cl

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTR1A known ✓ P08908 1/20 0.30
HTR7 known ✓ P34969 1/20 0.30
HTR2B known ✓ P41595 1/20 0.30
SIGMAR1 known ✓ Q99720 1/20 0.30
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
TAAR1 Q96RJ0 1/20 0.32
TMEM97 Q5BJF2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7640986 0.94 CYP1A2 (0.32) CYP1A2CYP2C19
Hydrochloric Acid SCHEMBL8361434 0.89 CYP1A2 (0.36) CYP1A2CYP2C19TAAR1
Hydrochloric Acid SCHEMBL4009565 0.87 CYP1A2 (0.32) CYP1A2CYP2C19
Hydrochloric Acid SCHEMBL8357734 0.87 CYP1A2 (0.35) CYP1A2CYP2C19
Hydrochloric Acid SCHEMBL4009368 0.85 CYP1A2 (0.33) CYP1A2CYP2C19TAAR1
Hydrochloric Acid SCHEMBL7639799 0.83 CYP1A2 (0.32) CYP1A2CYP2C19
Hydrochloric Acid SCHEMBL6056178 0.82 NCEH1 (0.32) CYP1A2CYP2C19
Hydrochloric Acid SCHEMBL5171036 0.81 CYP2A6 (0.33) CYP1A2CYP2C19TAAR1
Hydrochloric Acid SCHEMBL8357814 0.81 TAAR1 (0.32) CYP1A2CYP2C19TAAR1
SCHEMBL7049863 0.80 CYP2A6 (0.34) CYP1A2CYP2C19TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601777-B2 Method for the production of an aqueous polymer dispersion BASF AKTIENGESELLSCHAFT (DE) 2009-10-13 US disclosed
US-20050176875-A1 Method for the production of an aqueous polymer dispersion BASF AKTIENGESELLSCHAFT (DE) 2005-08-11 US disclosed
US-6815490-B2 IMPROVE IMPACT STRENGTH, FLOWABILITY AND MELT PROCESSABILITY; INCLUDING AN ETHYLENE COPOLYMER BASELL POLYOLEFINE GMBH (DE) 2004-11-09 US disclosed
US-6812185-B2 IMPREGNATION OF A SUPPORT MATERIAL WITH AN IMPREGNATION SOLUTION COMPRISING THE METAL COMPONENT, WHEREIN THE IMPREGNATION SOLUTION FLOWS IN A DIRECTED STREAM THROUGH THE SUPPORT MATERIAL BASELL POLYOLEFINE GMBH (DE) 2004-11-02 US disclosed
US-20030236164-A1 Preparation of a metal-containing supported catalyst or a supported catalyst component by impregnation of a support material EQUISTAR CHEMICALS, LP 2003-12-25 US disclosed
US-20030176580-A1 Toughened propylene polymers having little tendency to white fracture EQUISTAR CHEMICALS, LP 2003-09-18 US disclosed
US-6589905-B1 By impregnating a supporting material with an impregnating solution containing the metal constituent, whereby the impregnating solution flows through the supporting material BASELL POLYOLEFINE GMBH (DE) 2003-07-08 US disclosed
US-6583253-B1 Films, fibers and moldings, heat sealable coating materials; metallocene catalyst BASELL POLYPROPYLEN GMBH (DE) 2003-06-24 US disclosed
US-6562478-B1 Sealable multilayer film made of a grafted terpolymer BASELL POLYOLEFINE GMBH (DE) 2003-05-13 US disclosed
US-6469111-B1 THE ANTISTATIC AGENT USED IS ZNO AND/OR ANHYDROUS MGO TO PREVENT BUILD UP ON REACTOR WALLS BASF AKTIENGESELLSCHAFT (DE) 2002-10-22 US disclosed
US-6265339-B1 PARTICULATE ORGANIC OR INORGANIC SUPPORT MATERIAL, A TRANSITION METAL COMPLEX AND A COMPOUND CAPABLE OF FORMING METALLOCENIUM IONS BASF AKTIENGESELLSCHAFT (DE) 2001-07-24 US disclosed
US-6248829-B1 BLEND OF ISOTACTIC PROPENE COPOLYMER AND PROPENE HOMOPOLYMER BASF AKTIENGESELLSCHAFT (DE) 2001-06-19 US disclosed
US-6127495-A Preparation of polymers of C2 -C12 -alkenes with the addition of a reaction retarder BASF AKTIENGESELLSCHAFT (DE) 2000-10-03 US disclosed
US-6114478-A IN STIRRED BED OF FINELY DIVIDED POLYMER FROM GAS PHASE KEPT IN MOTION BY MEANS OF STIRRER, THE TRANSITION METAL-CONTAINING CATALYST SOLID OF THE ZIEGLER-NATTA OR METALLOCENE CATALYST SYSTEM BEING FED TO REACTOR WITH C2-C8 ALK-1-ENE BASF AKTIENGESELLSCHAFT (DE) 2000-09-05 US disclosed
US-6096845-A Preparation of crystalline polymers by dispersion polymerization in the presence of metallocene catalyst systems BASF AKTIENGESELLSCHAFT (DE) 2000-08-01 US disclosed
US-6022935-A Preparation of polymers of alk-1-enes in the presence of a supported metallocene catalyst system and of antistatic agent BASF AKTIENGESELLSCHAFT (DE) 2000-02-08 US disclosed
US-5929185-A OBTAINED BY POLYMERIZATION OF MONOMERS AT FROM-50 TO 300 DEGREES C. AND FROM 0.5 TO 3000 BAR IN THE PRESENCE OF A CATALYST SYSTEM WHICH CONTAINS, AS ACTIVE COMPONENTS, A METALLOCENE COMPLEX AND A COMPOUND FORMING METALLOCENIUM IONS BASF AKTIENGESELLSCHAFT (DE) 1999-07-27 US disclosed
US-5912373-A Process for converting the achiral meso form of an ansa-metallocene complex into the chiral racemic form BASF AKTIENGESELLSCHAFT (DE) 1999-06-15 US disclosed
US-5892081-A REACTING TIN METALLOCENE WITH TRANSITION METAL HALIDE OR ALKOXIDE BASF AKTIENGESELLSCHAFT (DE) 1999-04-06 US disclosed
US-5840950-A Process for converting the achiral meso form or the racemate of an ansa-metallocene complex or mixtures thereof into one of its enantiomers BASF AKTIENGESELLSCHAFT (DE) 1998-11-24 US disclosed